CUSIP: G1125A108
What is CUSIP G1125A108?
CUSIP G1125A108 identifies BIOT - BIOTECH ACQUISITION COMPANY - CL A SHS in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP G1125A108:
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2023 Q2 | 0 | $0 | -$2,855,832 | 0 | |
| 2023 Q1 | 0 | $0 | -$225,826,694 | 0 | |
| 2022 Q4 | 22,366,477 | $225,826,694 | -$6,532,938 | $10.10 | 68 |
| 2022 Q3 | 23,003,556 | $228,231,000 | +$2,546,888 | $9.92 | 69 |
| 2022 Q2 | 22,695,462 | $224,652,000 | +$11,308,675 | $9.90 | 67 |
| 2022 Q1 | 22,063,008 | $217,440,000 | +$5,735,382 | $9.86 | 75 |
| 2021 Q4 | 21,483,819 | $211,397,170 | +$53,910,825 | $9.84 | 76 |
| 2021 Q3 | 15,041,083 | $146,497,000 | +$19,082,054 | $9.74 | 58 |
| 2021 Q2 | 13,085,561 | $126,532,000 | +$52,904,156 | $9.67 | 50 |
| 2021 Q1 | 7,206,486 | $69,998,000 | +$69,998,000 | $9.72 | 27 |